Related Experiment Video
Updated: Jul 19, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Nurses' communication of pharmacogenetic test results as part of discharge care
1Center for Applied Genomics & Precision Medicine, Duke University School of Medicine, 304 Research Drive, Box 90141, Durham, NC 27708, USA.
Insights
Pharmacogenetic (PGx) test results need clear communication pathways. We propose discussing PGx results during discharge, including them in summaries, and notifying primary providers to ensure patient understanding and optimal care.
Area of Science:
- Clinical Pharmacy
- Genetics in Medicine
- Patient Communication
Background:
- Pharmacogenetic (PGx) testing is increasingly used in hospitalized patients.
- Effective communication of PGx results to patients is crucial for current and future healthcare decisions.
- Current protocols for communicating PGx results during hospital stays require optimization.
Purpose of the Study:
- To propose a framework for timely and effective communication of pharmacogenetic (PGx) test results to patients.
- To define the roles of healthcare providers, particularly nurses, in communicating PGx findings.
- To identify necessary educational and clinical support for healthcare professionals.
Main Methods:
- Literature review on current pharmacogenetic testing and patient communication practices.
- Analysis of the implications of PGx results for patient care.
- Development of recommendations for integrating PGx result communication into clinical workflows.
Main Results:
- Prompt discussion of PGx results upon completion of testing is ideal.
- If not discussed promptly, results should be communicated during discharge.
- Inclusion in discharge summaries and notification of primary providers are recommended.
Conclusions:
- Clear communication strategies for pharmacogenetic (PGx) results are essential for patient care.
- Nurses are vital in discharge planning and require enhanced training and support for PGx communication.
- Revised curricula and clinical decision support tools are needed to empower nurses in this role.
Abstract:
As pharmacogenetic (PGx) testing is becoming integrated into routine clinical procedures for admitted hospital patients, consideration is needed as to when test results will be communicated to patients and by whom. Given the implications of PGx test results for current and future care, we propose that if results are not promptly discussed with patients when testing is completed, results should be discussed with patients during discharge care when possible, included in the printed or electronic discharge summary and a copy of the results sent to their primary provider. Nurses play an important role in discharge planning and care by providing patients with the necessary information and support to transfer from the hospital setting to an outpatient setting or to return to home and work. To promote nurses' ability to fulfill the role of communicating PGx test results, revised curricula and interprofessional and clinical decision support are needed.
Related Concept Videos
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenomics: Identification of New Drug Targets
